{"schema_version":"secwatch.filing_event.v1","accession":"0001759655-23-000023","form_type":"8-K","ticker":"PRVA","cik":"0001759655","company_name":"Privia Health Group, Inc.","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.440780+00:00","generated_at":"2026-06-18T22:27:17.677939+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Privia Health Q4 revenue $364.4M (+32% YoY); net income $17.8M vs loss; FY2022 above guidance","bullets":["Q4 revenue $364.4M (+32.4% YoY); operating income $2.2M vs loss $19.3M.","Q4 net income $17.8M ($0.14 diluted EPS) vs net loss $12.0M ($0.11 loss) YoY.","Non-GAAP adjusted net income $16.1M ($0.13 diluted), up 130% YoY.","FY2022 results at or above high end of guidance; Practice Collections growth 49.1%.","New market entries in CT, DE, NC, OH; three new ACOs; 2023 capitated lives +38% to 40,600."],"urls":{"canonical":"https://secwatch.observer/filing/0001759655-23-000023","json":"https://secwatch.observer/filing/0001759655-23-000023.json","markdown":"https://secwatch.observer/filing/0001759655-23-000023.md","text":"https://secwatch.observer/filing/0001759655-23-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000023/0001759655-23-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000023/prva-20230228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T22:27:17.677939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11eef0e8ac433436743d8e76ea841200620ea8bd","claim":"Privia Health Group, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $364.4 million, net income $17.8 million, EPS $0.14 per diluted share.","evidence_excerpt":"today announced financial and operating results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter Total revenue for the fourth quarter of 2022 was $364.4 million, compared to total revenue of $275.3 million for the prior year fourth quarter (+32.4%). Operating income for the fourth quarter of 2022 was $2.2 million, compared to operating","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000023/0001759655-23-000023-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$364.4 million"},{"label":"Net income","value":"$17.8 million"},{"label":"EPS","value":"$0.14 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"70538ff9533be2f8e6f4e13673bf1284379a1cb8","claim":"Privia Health Group, Inc. updated its full year ended December 31, 2022 guidance (reaffirmed).","evidence_excerpt":"Privia Health Reports Fourth Quarter 2022 Financial Results – FY 2022 Financial Results At or Above High End of Guidance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000023/0001759655-23-000023-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}